Movement Network Foundation Announces REX-Osprey Funds Files for First U.S. Movement ETF as Public Mainnet Beta Launches
First Movement ETF Filing Will Provide U.S. Investors with Exposure to Movement Ecosystem…
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024
SAN DIEGO--(BUSINESS WIRE)--$REVB #EARNINGS--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”),…
Phoenix Aviation Capital Acquires One Airbus A321neo Aircraft on Lease with IndiGo
DUBLIN and STAMFORD, Conn., March 6, 2025 /PRNewswire/ -- Phoenix Aviation Capital…
Indianapolis Prize Names Ugandan Wild Cat Protector Winner of Second Emerging Conservationist Award
INDIANAPOLIS, March 4, 2025 /PRNewswire/ -- The Indianapolis Prize, the world's leading award…
LinkGevity Awarded Innovate UK Smart Grant for Anti-NecroticResearch to Prevent Kidney Deterioration
March 04, 2025 04:00 ET | Source: LinkGevity LONDON, March 04, 2025…
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology…
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
February 28, 2025 17:00 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…
ORYZON Announces the Voting Results of February 2025 Extraordinary General Shareholders’ Meeting
February 28, 2025 09:14 ET | Source: Oryzon Genomics, S.A. All resolutions…
Shuttle Pharma Provides Corporate Update and Reports 2024 Results
GAITHERSBURG, Md., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc.…
Derm-Biomes DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug
VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc,…